[ Price : $8.95]
FDA accepts Roches MycoTOOL as the first commercially available mycoplasma test for release testing of a biopharmaceutical product...[ Price : $8.95]
ViroPharma Inc. initiates a Phase 2b study to evaluate the safety and efficacy of subcutaneous Cinryze in combination with Halozym...[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance, Providing Submissions in Electronic Format Summary Level Clinical Site Da...[ Price : $8.95]
FDA approves a Sucampo Pharmaceuticals supplemental NDA for Rescula ophthalmic solution to allow its use as a first-line therapeut...[ Price : $8.95]
Matrixx Initiatives recalls one lot of Zicam Extreme Congestion Relief nasal gel after finding a small amount of Burkholderia cepa...[ Price : $8.95]
Federal Register Notice: FDAs Drug Safety and Risk Management Advisory Committee will meet 1/24-25/13 to discuss drugs containing ...[ Price : $8.95]
Federal Register Notice: FDA plans a public hearing 2/7-8 to obtain information on the use of opioid drugs in treating chronic pai...[ Price : $8.95]
FDA is told by state representatives that the defining differences between compounding and manufacturing remain the major problem ...